Financials
Income statement
| Fiscal date | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|
| Total reported revenue | 620.3B | 628.7B | 506.5B | 548.3B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | 95.9B | 89.8B | 88.5B | 91.1B |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | 363M | 350M | 506M | 215M |
| Other income expense | 69.6B | 19.7B | 27.7B | 63.1B |
| Pretax income | 45.3B | 29.7B | 32.1B | 28.0B |
| Tax provision | 10.1B | 8.0B | 8.0B | 9.0B |
| Net income | 35.2B | 21.8B | 24.1B | 19.0B |
| Basic EPS | — | — | — | 34.7 |
| Diluted EPS | — | — | — | 34.7 |
| Basic average shares | — | — | — | 547.0M |
| Diluted average shares | — | — | — | 547.5M |
| EBITDA | — | — | — | — |
| Net income from continuing op. | — | — | — | — |
| Minority interests | -1.2B | -14M | -43M | -20M |
| Preferred stock dividends | — | — | — | — |